Leading the Field in Surfactant Copolymers for Cell and Tissue Protection
Maroon Biotech establishes CRADA with Walter Reed Research Institute to develop therapeutics for treatment of traumatic brain injury.
Can the effects of physical trauma to the human body be undone?
Dr. Raphael Lee MD, ScD, DSc is elected to American Academy of Arts and Sciences in 2022.
Call Us Today: (312) 432- 9820
Learn more about our technology focus
Maroon Biotech has developed a cost effective strategy to produce purified biopolymers for use in medical and laboratory research as well as in industrial protein manufacturing. Available polymers include poloxamers, polyethylene glycols, and other polyols. Contact us for more information.
Maroon’s surfactant chaperone technology can actually reduce the amount of brain tissue damaged by the lack of oxygen during a stroke, the third leading cause of death in the United States today. As a result, Maroon will be able to make a difference in the lives of hundreds of thousands of people each year.
Maroon Biotech has developed a new category of pharmaceuticals called surfactant chaperones. This technology has the capability to restore structure and viability to cells disrupted by physical and chemical trauma.
Combat has taken the lives of countless soldiers and civilians all over the world. Maroon has the technology to not only help save lives by healing injuries and damaged tissue sustained from military trauma that would lead to permanent disabilities if left untreated.